We are TAE Life Sciences

TAE Life Sciences (TLS) is a biologically-targeted radiation therapy company focused on developing novel treatment to improve the lives of patients with difficult-to-treat cancers.

photo-mosaic-work

A Total Solution

TAE Life Sciences is pushing the boundaries of science to create an innovative biologically targeted radiation therapy for cancer. We are the only company developing both the targeted boron drugs and a neutron beam system for BNCT.

We believe the evolution in BNCT will enable a paradigm shift in cancer care with the potential to improve the lives of patients with difficult-to-treat cancers.

Leadership Team

robert-hill-mt

Robert Hill

Chief Executive Officer
kendall-morrison-mt

Kendall Morrison, PhD

Chief Science Officer
anna-theriault-mt

Anna Theriault

GM Americas and Global Vice President Marketing
chad-lee-mt_24

Chad Lee, PhD

VP Product
michael-sandhu

Michael Sandhu

GM EMEAI
peter-stafford_2

Peter Stafford

GM APAC

Board of Directors

robert-hill-mt

Robert Hill

Chief Executive Officer, TAE Life Sciences
michl-binderbauer_2

Michl Binderbauer, PhD

Chief Executive Officer, TAE Technologies, Inc.
stuart-peterson_2

Stuart Peterson

Co-Founder and President, ARTIS Ventures
artem-smirnov_2

Artem Smirnov, PhD

Chief Technology Officer, TAE Technologies, Inc.

Clinical Advisory Board

Richard Amos, PhD

University College London, UK

Garth Cruickshank, MD, PhD

Emeritus Professor of Neurosurgery, University of Birmingham UK

Daniel Low, PhD

University of California, Los Angeles

Anand Mahadevan, MD

NYU Langone

Jack Phan, MD, PhD

UT MD Anderson Cancer Center

More than just a job. Transform Cancer Therapy.

Come join a team dedicated to enabling a new hope for cancer patients and their families.

Have questions about BNCT? Get answers on our new BNCT Forum